Diabetes & CV Disease
Sort by:
UCSF School of Medicine
Comorbidities at CROI 2024
FEATURING
Rebecca Abelman
- 116 views
- April 4, 2024
- 1
Insights From The World Congress of Nephrology 2024
Using Potassium-enriched Salt for Cardiovascular Prevention
FEATURING
Bruce Neal
- 599 views
- May 8, 2024
- 4
KDIGO
Emerging Injury Drivers-IgAN, MN, FSGS, Diabetic Nephropathy Defined
FEATURING
Carla Nester
- 402 views
- December 2, 2022
- 3
University of Colorado Department of Medicine
SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit
FEATURING
Amy Li
- 1,312 views
- May 23, 2022
- 5
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Reducing Cardiometabolic Risk with SGLT2i and GLP1-RA – How to Choose and in Who
FEATURING
Qin Yang
- 954 views
- November 24, 2023
- 5
ASPC 2018 Congress on CVD Prevention
Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a Seminal Transition in DM Management
FEATURING
Mikhail Kosiborod
- 977 views
- August 10, 2018
- 3
Chantal Mathieu
What Are The New Developments in Insulin Therapy for T1D? What Will Be The Future of T2D Therapy?
- 978 views
- December 2, 2020
- 5
Jeffrey Goldberger
Autonomic Control in Diabetes: Translational Perspective
- 1,012 views
- May 25, 2016
- 5
NYU Langone
Post-Operative Anti-Obesity Medications
FEATURING
Holly Lofton
- 612 views
- March 28, 2023
- 4
Emory Diabetes Education Training Academy
Antihyperglycemic Medication in Type 2 Diabetes: Overall Approach
FEATURING
Guillermo Umpierrez
- 1,219 views
- May 15, 2020
- 4
Omnipod®
Omnipod® 5 Pearls for Pediatrics
FEATURING
Gregory Forlenza,
Cari Berget
- 1,030 views
- September 1, 2023
- 3
The Texas Heart Institute
ACC/AHA Guideline Directed Heart Failure Management
FEATURING
Joseph Rogers
- 1,183 views
- October 18, 2022
- 5
Practical Ways to Achieve Targets in Diabetes Care
Management of Diabetes and Diabetic Kidney Disease: Q&A Discussion
- 118 views
- November 22, 2021
- 1
University of Colorado Department of Medicine
Cardio-Renal Risk Reduction Across the Spectrum of Type 2 DM
FEATURING
Anip Bansal
- 118 views
- May 23, 2022
- 1
National Lipid Association
Treatments for Maximizing Prevention of Microvascular Complications
FEATURING
Leah Wilson
- 411 views
- March 25, 2019
- 3
23rd Pan Arab Conference On Diabetes
GLP-1 Receptor Agonists: ADA/EASD Guidelines
- 119 views
- May 14, 2019
- 1
26th Annual San Diego Heart Failure Symposium
Effects of SGLT2 Inhibitors in Treating Heart Failure Patients Regardless of Their Glycemic Status
FEATURING
Gregg Fonarow
- 255 views
- December 16, 2020
- 2
3rd National Conference On Prevention Of Diabetes
Plant Based Diet in the Prevention and Treatment of Diabetes
FEATURING
Jennifer Rooke
- 637 views
- December 7, 2018
- 4
Penn Medicine Heart and Vascular Center
How Do I Safely Introduce and Monitor SGLT-2 Inhibitors?
FEATURING
Anastassia Amaro
- 643 views
- November 8, 2023
- 4
Practical Ways to Achieve Targets in Diabetes Care
ATDC 2022: Automated Insulin Delivery Treatment for New-Onset Type 1 Diabetes
FEATURING
Aaron Michels
- 423 views
- July 27, 2022
- 3